Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. - Wikidata - wikimedia - TriplyDB

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

http://www.wikidata.org/entity/Q43724345

about

Role of immunotherapy in the treatment of allergic asthma Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice Peptide immunotherapy for allergic disease.Actual therapeutic management of allergic and hyperreactive nasal disorders Early detection of allergic diseases in otorhinolaryngology Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled study Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses Further marches: allergic and non-allergic.Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.House dust allergy and immunotherapy.A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.Undertreatment of allergy: exploring the utility of sublingual immunotherapy.Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.Therapeutic effects and biomarkers in sublingual immunotherapy: a review.Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.Pharmacotherapy of allergic rhinitis: current options and future perspectives.Preventive capacity of allergen immunotherapy on the natural history of allergy Preventing progression of allergic rhinitis to asthma.Emerging drugs for allergic conjunctivitis.Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review.Immunotherapy in allergic rhinitis and lower airway outcomes.Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis.Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.Multiallergen-specific immunotherapy in polysensitized patients: where are we?Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis.Upregulated levels of human β-defensins in patients with seasonal allergic rhinitis after allergen-specific immunotherapy treatment.Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate.Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.

P2860

Q27021489-AB785C1F-401F-47C2-8E4E-DED51B8D544F Q31030974-B1C5FA31-6691-4818-88EF-F032B6DEFD55 Q33378244-BE261F89-721F-4987-B476-49EF5BAD1425 Q34446046-09A92702-2A28-4306-BC47-F27DB2D4191D Q35052674-49E40147-A05B-4F3A-AEE5-25249F3F8A79 Q35164800-C0864DFC-9091-4D71-B605-716D48A5A020 Q35427205-0C0E4EC4-57ED-4EB3-B7A4-C7ED967A28DF Q35427549-111D1099-37B9-43F8-85F2-67BC14094F38 Q35777126-5FEC01D3-F4DE-46C8-A324-873399C616AA Q36157889-E7D1D942-686D-4610-B2BA-5BCBA43093D8 Q36215069-9A71784C-0257-4B4C-8B14-F9E585E554FB Q36253230-C225CC66-0CD4-4409-A27B-E679C220B2BD Q36411170-655381C0-D936-46D0-B9E8-63F3C6B9689C Q36789966-42A6B5C7-7685-4FA4-A776-394F8B71E436 Q36826600-91C5F530-78C5-4067-817A-A6EF73FF0C0F Q36863569-3BE615C4-CAA7-4889-AB3D-BFC4CAAC76CA Q37215891-D6E7D22C-2989-4CAF-9679-EF6313C455D7 Q37355463-5E000B37-421F-46B5-A183-14D3CF0F2EB9 Q37459337-FFB0E672-B312-49BF-8F13-D0D09EBD405B Q37696401-894288B9-C552-473F-AC56-9B24F9DEE07B Q37820336-A42BB52A-407E-46D1-954D-08B8414212B9 Q37902666-D1637DC5-23A9-434D-9ED5-4C9B047CC14C Q37981739-DDE5A206-7F9A-4905-941D-252180F69BA4 Q38002411-0DB77E1E-80C1-4BDC-B7DE-5DEA8D19139A Q38025664-DC3C24D1-1AF3-4DAB-9D24-3C3802F4A3B1 Q38161991-A9DDF70D-BD05-44FE-9A79-8EB6DA0112CE Q38176377-3ADFDDAB-360F-4817-AAA7-ABF7CD523482 Q38177218-28400F12-6199-48D6-BEEA-488991FD014E Q38198760-27AA16CE-1691-4CF6-A4D0-9ACC5EF66EAA Q38667404-77602194-8276-4D81-B3BA-7776F8DED1EA Q38903486-8BA3D417-4263-48A2-99E6-C8C0604FBFEC Q38960803-3B8CB53F-BFF8-4D52-A36C-65AC2808A1C0 Q38968310-0BBEA211-06CE-41AA-B6C7-95C5277ABD2C Q39466603-41D60116-6065-4FE5-8980-E9A048B3732F Q40790855-6B0C689C-491B-48AC-8B2B-D06826759786 Q42153928-0F279DB8-6A5C-4E3D-A9C5-5512AEEE3A1F Q42428008-4C0B3BD1-5353-42E5-913A-F51869D048FB Q44201691-BE0391AD-BA16-4310-8BC3-CCD323E886D9 Q44680424-C3C8E160-D3F5-45B7-9593-B804BAAAC568 Q45088211-AD4F9F12-8CE8-4283-A2BC-85348FCD7C2F

P2860

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

http://www.wikidata.org/entity/Q43724345

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Prevention of new sensitizatio ...... or not. A retrospective study.

@en

Prevention of new sensitizatio ...... or not. A retrospective study.

@nl

type

label

Prevention of new sensitizatio ...... or not. A retrospective study.

@en

Prevention of new sensitizatio ...... or not. A retrospective study.

@nl

prefLabel

Prevention of new sensitizatio ...... or not. A retrospective study.

@en

Prevention of new sensitizatio ...... or not. A retrospective study.

@nl

P1433

Q43724345-9D5A8D45-37F0-4BE0-9A2D-F6AD002BFF46

P1476

Q43724345-37701439-DF60-49E8-897A-2DC614E39B61

P2093

Q43724345-24FF235E-3BC9-4B40-9603-DEBE588DDC35

Q43724345-6A29822F-4B79-45F8-8B7E-8ECB32950912

Q43724345-729D699A-C434-4B4A-B5FC-B2B55090A3CB

Q43724345-8019168A-3816-44B2-8A14-39B638A92C50

Q43724345-FE63877C-473C-4E70-B45F-E5C56D6C7F0F

P2860

Q43724345-2DDBF5AA-65AD-4B85-9EC3-5711B754182C

Q43724345-35898B27-DC1E-4223-9C15-EE0FE20E6720

Q43724345-3F223453-9DE9-4755-82AC-CBA39888F029

Q43724345-6DDAA3B3-3827-41E0-A62B-E2186D8407C5

Q43724345-79F43AB8-6F99-4015-A75F-EA4FE0A8D175

Q43724345-8E780639-3245-4578-8505-16C5C069D39D

Q43724345-A0E11BA5-BFB3-483D-A71C-ABE969D973A9

Q43724345-A33DE356-D9BA-420E-B654-03C0CFE03647

Q43724345-B6C67DDA-9D48-455E-BD88-CBFEBA18400B

Q43724345-C1C995E6-2CFC-469F-84CE-C17B606C0E30

P304

Q43724345-C3269C56-191A-4ABC-BF13-C5E50084572D

P31

Q43724345-2AB95F01-3AEC-42CC-AAA4-DDECB31CCCED

P356

Q43724345-38C4A64A-9026-4CEE-804A-6349028BC6FC

P433

Q43724345-3EAC00F8-6A16-474D-ACA9-B441DB36244B

P478

Q43724345-F8DAD958-8A7E-4F29-81EE-9719DEA9D7A2

P50

Q43724345-1A173294-5F23-44CD-B66D-8BA402FF87D8

Q43724345-FA2C6305-E9CD-4F53-841B-30D3D1A53993

P577

Q43724345-4B150C13-E0C9-4905-925E-24CD97E97DAA

P5875

Q43724345-E54DACF4-B82A-4127-8F14-1CF1F8CBFE68

P698

Q43724345-75A73ED6-610A-4AC6-A04D-36AF09516A5F

P921

Q43724345-C53BC9B0-2D75-466C-B073-99577B1BA76F

P356

J.1365-2222.2001.01027.X

P1433

Clinical & Experimental Allergy

P1476

Prevention of new sensitizatio ...... or not. A retrospective study

@en

P2093

F Purello-D'Ambrosio

http://www.w3.org/2001/XMLSchema#string

P Puccinelli

http://www.w3.org/2001/XMLSchema#string

R A Merendino

http://www.w3.org/2001/XMLSchema#string

S Isola

http://www.w3.org/2001/XMLSchema#string

S Parmiani

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

Immunologic mechanisms of specific immunotherapy.

Long-term clinical efficacy of grass-pollen immunotherapy.

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge.

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen.

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis.

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

P304

1295-1302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2222.2001.01027.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Sebastiano Gangemi

Luisa Ricciardi

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11816028

http://www.w3.org/2001/XMLSchema#string

P698

11529901

http://www.w3.org/2001/XMLSchema#string

P921